Full Text (PDF)
Selection of a CMO is critical to biologic drug development; and the primary selection criterion is experience. How do biotech companies measure experience? CMO experience can be measured in many ways — primary metrics include (1) total number of GMP processes developed by a CMO; (2) number of projects involving your strain; (3) number of projects involving your product type; (4) GMP production success rate; (5) total number of GMP lots produced; and (6) number of quality audits.”
Eurogentec's biologics division is specialized in the manufacturing of biopharmaceuticals from microbial sources: bacteria, yeast, and biosafety level 2 (BSl-2) organisms. Eurogentec has manufactured according to GMP since 1994.
Host Cell Experience: Microbial Experts
Eurogentec has expertise with E. coli, P. pastoris, H. polymorpha, S. cerevisiae, and numerous BSl-2 organisms.
Chemistry Experience: Conjugation ExpertsMaleimide
Glutaraldehyde
Other chemistries available
Recombinant proteins
Plasmid DNA
Protein-PEG conjugations
Protein-protein conjugations
Protein-peptide conjugations
Multiproduct facility
Separate HVAC systems
GMP fermentation suites: 80 L, 150 L, 500 L fermenters
2 GMP purification suites
1 GMP sterile filtration suite
FastTrack
OptiTrack
Dr. Pascal Bolon is biologics sales and marketing manager at Eurogentec SA, Rue du Bois Saint-Jean 5, 4102 Seraing, Belgium; +32 4- 366-6116; biologics@eurogentec.com.
Facility Design Strategies for Single-Use Technologies
Please join us for a free webinar addressing strategies for facility design in biopharmaceutical manufacturing:
Wednesday, 29 February 2012
8:00 AM and 1:00 PM EST
Presented by:
Ingrid Long, MSc
Research Engineer
GE Healthcare Life Sciences
During the webinar, Ms. Long will discuss the impact of different strategies for facility design, with a focus on the following topics:
* Replacement of traditional equipment with the single-use equivalent
* Biopharmaceutical manufacturing in a single room
* Benefits of facility design with respect to cost, risk, and flexibility
Development of a Plant-Made Pharmaceutical Production Platform






